Condition: Ischemic Stroke · Sponsor: Raul Nogueira
A phase III, randomized, multi-center, investigational, open label clinical trial that will examine whether treatment with endovascular thrombectomy is superior to standard medical therapy alone in patients who suffer a Distal Medium Vessel Occlusion Ischemic Stroke within 12 hours from time last seen well
This description comes directly from the study's public registry record.
Mohamed Doheim, MD · 1-516-854-0487 · doheimmf@upmc.edu
Emma Gyurisin, MPH · 4126779128 · gyurisinek2@upmc.edu
Always discuss trial participation with your own doctor first.
| Grady Health System | Atlanta, Georgia, United States | Not Yet Recruiting |
| UI Health Care Medical Center | Iowa City, Iowa, United States | Recruiting |
| ProMedica | Toledo, Ohio, United States | Recruiting |
| University of Pittsburgh | Pittsburgh, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05983757